Control of invasive pulmonary aspergillosis with oral itraconazole in a bone marrow transplant patient
Open Access
- 1 January 1992
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 24 (1) , 73-79
- https://doi.org/10.1016/0163-4453(92)91066-k
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Splenic microabscesses in the immune-compromised patientJournal of Pediatric Surgery, 1989
- Treatment of invasive aspergillosis with itraconazoleThe American Journal of Medicine, 1989
- A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbitJournal of Antimicrobial Chemotherapy, 1987
- Primary Cutaneous Aspergillosis Associated with Hickman Intravenous CathetersNew England Journal of Medicine, 1987
- A clinical and serological study of the effect of itraconazole in the management of invasive aspergillosisSerodiagnosis and Immunotherapy in Infectious Disease, 1987
- Early Experience with Itraconazole in Vitro and in Patients: Pharmacokinetic Studies and Clinical ResultsClinical Infectious Diseases, 1987
- Clinical Experience With Amphotericin B in Acute Myelogenous LeukemiaSouthern Medical Journal, 1986
- IMMUNOLOGIC RECOVERY IN HUMAN MARROW GRAFT RECIPIENTS GIVEN CYCLOSPORINE OR METHOTREXATE FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASETransplantation, 1984
- ACUTE RENAL TOXICITY WITH COMBINED USE OF AMPHOTERICIN B AND CYCLOSPORINE AFTER MARROW TRANSPLANTATIONTransplantation, 1983
- Increased Pulmonary Superinfections in Cardiac-Transplant Patients Undergoing Primary Cytomegalovirus InfectionNew England Journal of Medicine, 1978